Table 2.
Variable | Categories | Distribution | Baseline model | Model with baseline covariates and additionally | |||
---|---|---|---|---|---|---|---|
IFNL4 genotype | HCV-RNA | IFNL4 genotype & HCV-RNA | IFNL4 & HCV-RNA & interaction HCV-RNA/Race | ||||
β (std err) | β (std err) | β (std err) | β (std err) | β (std err) | |||
Race | Caucasian | 52.7% | Ref | Ref | Ref | Ref | Ref |
Non-white | 48.3% | -0.85 (0.241) | -0.58 (0.257) | -0.90 (0.244) | -0.62 (0.261) | 2.92 (2.110) | |
Sex | Male | 65.4% | Ref | Ref | Ref | Ref | Ref |
Female | 34.6% | 0.73 (0.262) | 0.74 (0.266) | 0.68 (0.264) | 0.68 (0.269) | 0.63 (0.270) | |
Ishak fibrosis score | 0 | 10.6% | -0.29 (0.156) | -0.33 (0.159) | -0.29 (0.158) | -0.33 (0.161) | -0.33 (0.162) |
(ordinal) | 1-2 3-4 5-6 | 52.9% | |||||
1-2 | 29.7% | ||||||
3-4 | 6.9% | ||||||
AST/ALT ratio | per quartile | -0.39 (0.117) | -0.34 (0.119) | -0.37 (0.118) | -0.32 (0.121) | -0.31 (0.120) | |
(ordinal) | |||||||
IFNL4 | ∆G/(∆G or TT) | 72.0% | - | Ref | - | Ref | Ref |
TT/TT | 28.0% | - | 0.90 (0.279) | - | 0.93 (0.282) | 0.92 (0.282) | |
log10HCV-RNA level | - | 6.5(5.6,6.8) | - | - | -0.38 (0.158) | -0.41 (0.162) | -0.20 (0.196) |
(median, IQRα) | |||||||
HCV-RNA:Race interact. | -0.57 (0.340) | ||||||
| |||||||
AUC* | 0.701 | 0.725 | 0.712 | 0.738 | 0.739 |
IQR - Intra-quartile range (25th percentile - 75th percentile);
AUC based on c-statistics from SAS PROC logistic